About Paliseul Pharma
Paliseul Pharma is a private limited company (BV/SRL) based in Paliseul, founded in 2005. Its main activity is classified as "Detailhandel in farmaceutische producten". For the 2025 financial year, Paliseul Pharma reported a profit of €183,716. That makes 13 profitable financial years in a row for Paliseul Pharma. Revenue was not published, which is common for abbreviated accounts. The gross margin came to €691,915, up 46% on 2024. It employed an average of 3.4 full-time equivalents. Equity stands at €906,153, a solvency ratio of 34%. In 2006 it was €5,426. 20 annual accounts are available, covering 2006 to 2025.
- Sectors
- Pharmacies
- Signals
-
ProfitableProfitable € 184K
The company reported a positive net result in the latest financial year.
Strong equityStrong equity € 906KStrong equity provides a buffer against setbacks.
Low riskLow risk 34.4%Good solvency (> 30%) points to long-term financial stability.
Good liquidityGood liquidity 1.94A healthy current ratio (≥ 1.5): enough current assets to cover short-term debt.
Positive cashflowPositive cashflow € 339KPositive operating cash flow in the latest financial year.
Positive EBITDAPositive EBITDA € 430KPositive EBITDA: operating activities are profitable.
Healthy social debtHealthy social debt 14.3%Social debts stay manageable relative to personnel costs.
- Shareholders
- Po² 99%
Financial ratios
|
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2025
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2024
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2023
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
2022
max) max = w;
}
}
const wClamped = Math.max(120, Math.min(800, max));
colWidths[''] = wClamped;
save && save();
})(event)">
|
|---|---|---|---|---|
|
€
692K
|
€
473K
|
€
424K
|
€
413K
|
|
|
€
430K
|
€
259K
|
€
256K
|
€
234K
|
|
|
€
184K
|
€
180K
|
€
190K
|
€
169K
|
|
|
€
906K
|
€
832K
|
€
692K
|
€
562K
|
|
|
34.44%
|
30.16%
|
58.77%
|
51.00%
|
|
|
€
1.73M
|
€
1.93M
|
€
486K
|
€
540K
|
|
|
€
583K
|
€
448K
|
€
272K
|
€
231K
|
|
|
3.40
|
3.90
|
3.20
|
3.40
|
Publications 14
All publications- Statuts (Traduction, Coordination, Autres Modifications, ) - Modification Forme Juridique - Denomination - Demissions, Nominations 09/02/2024
- Me. - Comptes Annuels 31.12.2015, App 10.06.2016, Dpt 30.07.2016 16389-0357-017 05/08/2016
- Me. - Comptes Annuels 31.12.2014, App 12.06.2015, Dpt 30.06.2015 15244-0147-019 06/07/2015
- Demissions, Nominations 22/04/2015
- Me. - Comptes Annuels 31.12.2013, App 13.06.2014, Dpt 30.06.2014 14251-0405-018 07/07/2014
Frequently asked questions
Answers to the most common questions about Paliseul Pharma, based on official government data and the filed annual accounts.
What is the VAT number of Paliseul Pharma?
The VAT number of Paliseul Pharma is BE0874.952.569.
How many employees work at Paliseul Pharma?
In 2025, Paliseul Pharma employed 3.40 full-time equivalents (FTE).
When was Paliseul Pharma established?
Paliseul Pharma was founded in 07-07-2005.
What is the official address of Paliseul Pharma?
The official address of Paliseul Pharma is Grand-Place 16 Paliseul 6850.
What is the legal form of Paliseul Pharma?
The juridical form of Paliseul Pharma is Private limited company (BV/SRL).
What is the annual revenue of Paliseul Pharma?
The 2025 accounts of Paliseul Pharma do not report revenue. Smaller companies that file abbreviated accounts are not required to publish it.
Is Paliseul Pharma a reliable company?
Paliseul Pharma is a registered Rechtspersoon with company number 0874.952.569 and can be verified through the official CBE database.
What is the credit limit of Paliseul Pharma?
The estimated credit limit of Paliseul Pharma is €457,433.
Is Paliseul Pharma still active?
Paliseul Pharma currently has the status "Normal situation" and is active.